Ridgefield, CT, United States of America

Gary Mathias

This inventor holds 10 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Thetis Pharmaceuticals LLC, Beth Israel Deaconess Medical Center, Inc., Other. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gary Mathias. Retrieved from https://idiyas.com/inventor/gary-mathias

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 50.0

 

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Certainly! Here is an article about inventor Gary Mathias based on the provided data:

Title: Unveiling the Innovations of Inventor Gary Mathias

Introduction:

Diving into the realm of innovative minds, Gary Mathias emerges as a prominent figure in the field of cancer therapy and specialized pro-resolving mediators. Hailing from Ridgefield, CT (US), Mathias has made significant strides in the world of inventions with a total of 9 patents under his name.

Latest Patents:

1. Compositions and methods for cancer therapy: This patent revolves around the utilization of compositions comprising resolvins in the treatment of cancer, showcasing Mathias' commitment to advancing cancer therapy.

2. Compositions and methods relating to salts of specialized pro-resolving mediators: Delving deep into the realm of inflammation, this patent highlights Mathias' focus on combating chronic or excessive inflammation through specialized pro-resolving mediators.

Career Highlights:

Throughout his career, Gary Mathias has contributed his expertise to companies such as Thetis Pharmaceuticals LLC, where his innovative spirit has shaped groundbreaking solutions in the medical field. His visionary approach has led to the development of cutting-edge technologies aimed at revolutionizing cancer therapy and inflammation treatment.

Collaborations:

Collaboration lies at the heart of innovation, and Mathias has been privileged to work alongside esteemed colleagues such as Frank C. Sciavolino and Michael C. Van Zandt. Together, they have synergized their skills to drive forward transformative ideas and bring them to fruition.

Conclusion:

In conclusion, Gary Mathias stands as a beacon of innovation, with his patents paving the way for advanced cancer therapies and inflammation treatments. His collaborative efforts and dedication to pushing boundaries in the medical domain underscore his pivotal role in shaping the future of healthcare.

If you have any more specific requests or need further information, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…